Summary
The global COVID-19 Saliva-Based Detection Kits Market reached a valuation of US$ 1.6 billion in 2021, with PCR-based kits commanding a dominant 73% share, according to Fact.MR. Despite significant growth during the pandemic, the market is projected to decline at
Source: Openpr.com
Exclusive AI-Powered News Insights (For Members only)
Disclaimer:This content is AI-generated from various trusted sources and is intended for informational purposes only. While we strive for accuracy, we encourage you to verify details independently. Use the contact button to share feedback on any inaccuracies—your input helps us improve!
